Carregant...
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis
Glioblastoma is a rare and aggressive primary brain tumor with incidence of 5 per 100,000 annually. We report a 50-year-old woman diagnosed with glioblastoma within 3 years of induction of fingolimod therapy for relapsing-remitting multiple sclerosis. Fingolimod, an immunomodulating agent used in th...
Guardat en:
| Publicat a: | J Clin Neurosci |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4925177/ https://ncbi.nlm.nih.gov/pubmed/26970935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocn.2016.02.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|